Crystal structure-based studies of cytosolic sulfotransferase

Journal of Biochemical and Molecular Toxicology

Volumn 15, Issue 2, 2001, Pages 67-75

  Yoshinari, Kouichi ^a   Petrotchenko, Evgeniy V ^a   Pedersen, Lars C ^a   Negishi, Masahiko ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

3 phosphoadenosine 5 phosphosulfate; Sulfation; Sulfotransferases; X ray crystal structures

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; ARYL SULFOTRANSFERASE; CATECHOLAMINE SULFOTRANSFERASE; DOPAMINE SULFOTRANSFERASE; ESTROGEN SULFOTRANSFERASE; HEPARAN SULFATE; HYDROLASE; HYDROXYSTEROID SULFOTRANSFERASE; N DEACETYLASE; N SULFOTRANSFERASE 1; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM; BINDING SITE; BIOCHEMISTRY; BIOLOGY; CRYSTAL STRUCTURE; CYTOSOL; DEVELOPMENT; DONOR; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GOLGI COMPLEX; GROWTH; GUINEA PIG; HUMAN; IMMUNITY; INFORMATION; LETHALITY; MAMMAL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; SULFATION; X RAY ANALYSIS;

ANIMALS; BINDING SITES; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; CYTOSOL; DNA, COMPLEMENTARY; HUMANS; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PHOSPHOADENOSINE PHOSPHOSULFATE; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES;

BACTERIA (MICROORGANISMS);

EID: 0035044806     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.1     Document Type: Article

References (61)

1. Sulfate activation and transfer
2. Sulfation and sulfotransferases: Introduction. Changing view of sulfation and the cytosolic sulfotransferases
3. Sulfotransferases
4. Steroid sulfotransferases
5. Structure and function of sulphotransferases
6. N-hydroxy-2-acetylaminofluorene sulfotransferase: Its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver
7. Sulfation and sulfotransferases: Part IV. Bioactivation of mutagens via sulfation
8. Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification
9. Oestrogen sulfotransferase: Molecular cloning and sequencing of cDNA for the bovine placental enzyme
10. Pharmacogenetics of sulfotransferase
11. Sulfation and sulfotransferases: Part I. Sulfotransferase molecular biology: cDNAs and genes
12. Structural similarity and diversity of sulfotransferases
13. Diversity and functions of glycosaminoglycan sulfotransferases
14. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice
15. Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting
16. Molecular cloning and expression of an amine sulfotransferase cDNA: A new gene family of cytosolic sulfotransferases in mammals
17. Chimeric flavonol sulfotransferases define a domain responsible for substrate and position specificities
18. Identification of amino acid residues critical for catalysis and cosubstrate binding in the flavonol 3-sulfotransferase
19. The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen. sulfotransferase and mutational analysis
20. Mutational analysis of domain II of flavonol 3-sulfotransferase
21. The 3′-terminal exon of the family of steroid and phenol sulfotransferase genes is spliced at the N-terminal glycine of the universally conserved GXXGXXK motif that forms the sulfonate donor binding site
22. Proposed active site domain in estrogen sulfotransferase as determined by mutational analysis
23. A P-loop related motif (GxxGxxK) highly conserved in sulfotransferases is required for binding the activated sulfate donor
24. The P-loop-a common motif in ATP- and GTP-binding proteins
25. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3
26. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: Site-directed mutagenesis and kinetic studies
27. Structural characterization of human aryl sulphotransferases
28. Mutational analysis of the substrate binding/catalytic domains of human M form and P form phenol sulfotransferases
29. Crystal structure of estrogen sulphotransferase
30. Crystal structure of human catecholamine sulfotransferase
31. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity
32. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/ N-sulfotransferase 1
33. Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase
34. Conserved structural motifs in the sulfotransferase family
35. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase
36. Substrate gating confers steroid specificity to estrogen sulfotransferase
37. On the mechanism of aryl sulfotransferase
38. Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase
39. Evidence for an ordered reaction mechanism for bile salt: 3′phosphoadenosine-5′-phosphosulfate: Sulfotransferase from rhesus monkey liver that catalyzes the sulfation of the hepatotoxin glycolithocholate
40. Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain
41. Novel flavonol 3-sulfotransferase. Purification, kinetic properties, and partial amino acid sequence
42. X-ray structure of the magnesium(II)-ADP-vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 A resolution
43. A1F3 mimics the transition state of protein phosphorylation in the crystal structure of nucleoside diphosphate kinase and MgADP
44. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate
45. Site-directed mutagenesis of rat hepatic hydroxysteroid sulfotransferases
46. A role of Lys614 in the sulfotransferase activity of human heparan sulfate N-deacetylase/N-sulfotransferase
47. Site-directed mutagenesis of the substrate-binding cleft of human estrogen sulfotransferase
48. Isolation of two distinct 3-hydroxysteroid sulfotransferases from the guinea pig adrenal. Evidence for 3α-hydroxy versus 3β-hydroxy stereospecificity
49. Molecular cloning of a chiral-specific 3α-hydroxysteroid sulfotransferase
50. Molecular cloning and expression of a guinea pig 3-hydroxysteroid sulfotransferase distinct from chiral-specific 3α-hydroxysteroid sulfotransferase
51. Identification by chimera formation and site-selected mutagenesis of a key amino acid residue involved in determining stereospecificity of guinea pig 3-hydroxysteroid sulfotransferase isoforms
52. Placental estrogen biosynthesis during human pregnancy
53. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer
54. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture
55. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: A metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts
56. Human dehydroepiandrosterone sulfotransferase pharmacogenetics: Quantitative Western analysis and gene sequence polymorphisms
57. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype
58. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines
59. Phenol sulphotransferase SULT1A1 polymorphism: Molecular diagnosis and allele frequencies in Caucasian and African populations
60. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene
61. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy